Lon Schneider (Keck School of Medicine of USC)

'About as true as say­ing the earth is flat': Alzheimer's ex­pert picks apart Bio­gen's Aduhelm man­u­script

Lon Schnei­der, the Uni­ver­si­ty of South Cal­i­for­nia pro­fes­sor who di­rects the Cal­i­for­nia Alzheimer’s Dis­ease Cen­ter, has been one of the most vo­cal crit­ics of Bio­gen’s de­vel­op­ment pro­gram for ad­u­canum­ab. Wary from the be­gin­ning, he picked apart the da­ta that Bio­gen pre­sent­ed along the way and, when the FDA stamped its ap­proval on Aduhelm, was among a group of ex­perts to call for its “ac­cel­er­at­ed with­draw­al” and ap­plaud­ed the CMS’ de­ci­sion to re­strict cov­er­age.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.